University Clinic Giessen and Marburg - Campus Giessen
Giessen, Hesse, 35392, Germany
NCT Number: NCT03039959
Predictive value of renal venous flow profiles for adverse outcomes in patients with right heart failure
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Giessen, Hesse, 35392, Germany
Persistent congestion with deteriorating renal function is an important cause of adverse outcomes in heart failure. The investigators aimed to characterize new Doppler ultrasonography approaches to evaluate the continuum of renal congestion. Pulmonary hypertension is the most common precursor to right heart failure and thus represents an ideal scenario to study congestion. The second cohort comprises consecutive Cardiology inpatients aged ≥18 years with a new or pre-existing diagnosis of heart failure who are referred to the consultant nephrologist with a history of diuretic-resistant fluid overload and impaired renal function. The investigators choose patients with heart failure to broaden the findings to the most common clinical entity of right ventricular failure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Pulmonary hypertension cohort:
Exclusion criteria
Heart failure cohort:
Exclusion criteria
same as in the discovery cohort except pre-existing acute kidney injury
No intervention
Time frame: 1 year post-discharge
Any hospitalization for worsening of pulmonary hypertension, lung transplantation, or need for escalation of pulmonary hypertension-specific therapy, and death from any cause
Time frame: 1 year post-discharge
Unscheduled hospitalization or unscheduled office visit for heart failure and new onset renal replacement therapy
University of Giessen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03629340
Cardiovascular Diseases, Heart Diseases
San Francisco, California, United States
View Trial DetailsNCT06671171
Arterial Occlusive Diseases, Arteriosclerosis
Hong Kong
View Trial DetailsNCT07512310
Cardiovascular Diseases, Heart Diseases
Essen, Germany
View Trial DetailsNCT05996562
Cardiovascular Diseases, Heart Diseases
Lisbon, Portugal
View Trial Details